View Older Stories View More Recent Stories

Feb 14, 2018 02:52PM Form SC 13G/A AGENUS INC Filed by: QVT Financial LP
Feb 14, 2018 02:49PM Form SC 13G/A PALATIN TECHNOLOGIES Filed by: QVT Financial LP
Feb 14, 2018 02:46PM Form SC 13G/A pdvWireless, Inc. Filed by: QVT Financial LP
Jan 16, 2018 08:28AM Form SC 13D/A Arbutus Biopharma Corp Filed by: QVT Financial LP
Nov 14, 2017 03:34PM Form 13F-HR QVT Financial LP For: Sep 30
Oct 17, 2017 09:14AM Form SC 13D/A Arbutus Biopharma Corp Filed by: QVT Financial LP
Aug 23, 2017 05:06PM Translarity Acquires BucklingBeam to Deliver Advanced Probe Card Solutions for Technology Acceleration
Aug 14, 2017 01:22PM Form 13F-HR QVT Financial LP For: Jun 30
May 15, 2017 12:46PM Form 13F-HR QVT Financial LP For: Mar 31
Feb 21, 2017 05:02PM Form SC 13G/A China Zenix Auto Interna Filed by: QVT Financial LP
Feb 14, 2017 02:17PM Form 13F-HR QVT Financial LP For: Dec 31
Feb 10, 2017 05:17PM Form SC 13G/A Myovant Sciences Ltd. Filed by: QVT Financial LP
Feb 10, 2017 04:28PM Form SC 13G Myovant Sciences Ltd. Filed by: QVT Financial LP
Feb 9, 2017 04:40PM Form SC 13G/A AEHR TEST SYSTEMS Filed by: QVT Financial LP
Feb 9, 2017 04:23PM Form SC 13G/A PALATIN TECHNOLOGIES Filed by: QVT Financial LP
Feb 9, 2017 04:19PM Form SC 13G/A pdvWireless, Inc. Filed by: QVT Financial LP
Feb 9, 2017 10:53AM Form SC 13G/A CYTRX CORP Filed by: QVT Financial LP
Feb 9, 2017 10:51AM Form SC 13G/A Ocera Therapeutics, Inc. Filed by: QVT Financial LP
Feb 3, 2017 04:47PM Form SC 13G AGENUS INC Filed by: QVT Financial LP
Jan 11, 2017 09:11AM Landauer (LDR) Appoints New Board Member as Part of Agreement with Gilead Capital LP
Jan 11, 2017 09:00AM Landauer Agrees to Appoint Jeffrey A. Strong to Board of Directors and Announces Agreement with Gilead Capital LP
Nov 28, 2016 04:14PM Form SC 13G Hunter Maritime Acquisit Filed by: QVT Financial LP
Nov 14, 2016 03:00PM Form 13F-HR QVT Financial LP For: Sep 30
Oct 12, 2016 08:00AM Myovant Sciences Announces Appointment of Board of Directors
Aug 22, 2016 04:57PM Form SC 13G SEQUENOM INC Filed by: QVT Financial LP
Aug 15, 2016 05:13PM Form 13F-HR QVT Financial LP For: Jun 30
Jul 19, 2016 11:28AM SoftBank bid for ARM catches some hedge funds off guard
Jul 14, 2016 06:03AM Form SC 13D Arbutus Biopharma Corp Filed by: QVT Financial LP
Jul 13, 2016 05:31PM Form SC 13D Axovant Sciences Ltd. Filed by: QVT Financial LP
May 23, 2016 08:00AM Paul Singer, Founder and CEO of Elliott Management Corp., and Afsaneh Beschloss, Founder and CEO of Rock Creek Group, Honored; More Than 100 Investors, Consultants, Managers and Rising Stars Nominated
May 16, 2016 05:38PM Form 13F-HR QVT Financial LP For: Mar 31
Feb 17, 2016 04:25PM Form SC 13G pdvWireless, Inc. Filed by: QVT Financial LP
Feb 17, 2016 06:04AM Form SC 13D/A Arbutus Biopharma Corp Filed by: QVT Financial LP
Feb 16, 2016 03:52PM Form SC 13G/A Oncothyreon Inc. Filed by: QVT Financial LP
Feb 16, 2016 03:45PM Form SC 13G/A Mirati Therapeutics, Filed by: QVT Financial LP
Feb 16, 2016 02:42PM Form 13F-HR QVT Financial LP For: Dec 31
Feb 11, 2016 06:07AM Form SC 13G/A Retrophin, Inc. Filed by: QVT Financial LP
Feb 11, 2016 06:07AM Form SC 13G/A PALATIN TECHNOLOGIES Filed by: QVT Financial LP
Feb 11, 2016 06:06AM Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: QVT Financial LP
Feb 10, 2016 05:28PM Form SC 13G/A ARROWHEAD RESEARCH CORP Filed by: QVT Financial LP
Feb 10, 2016 05:28PM Form SC 13G/A AGENUS INC Filed by: QVT Financial LP
Feb 10, 2016 05:27PM Form SC 13G/A Ocera Therapeutics, Inc. Filed by: QVT Financial LP
Feb 10, 2016 05:27PM Form SC 13G/A CYTRX CORP Filed by: QVT Financial LP
Nov 16, 2015 01:44PM Form 13F-HR QVT Financial LP For: Sep 30
Oct 23, 2015 05:20PM Form SC 13G Ocera Therapeutics, Inc. Filed by: QVT Financial LP
Oct 5, 2015 09:00AM Translarity Appoints Jeff Kuhn to Board of Directors
Sep 21, 2015 07:15AM Akari Therapeutics Closes $75 Million Private Placement
Sep 18, 2015 07:32AM Celsus Therapeutics (CLTX) Closes Acquisition of Volution Immuno Pharma
Sep 18, 2015 07:32AM Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Completion of Acquisition and Formation of Complement C5 Inhibitor Company Akari Therapeutics Plc
Sep 8, 2015 04:09PM AveXis Secures $65 Million in Financing
View More Recent Stories View Older Stories